Events

Title: Cancer detection in 2022: Can a blood test really find 30 different types of cancer in dogs? Description: The session sponsored by PetDx will review data from the CANcer Detection in Dogs study that validates PetDx’s “liquid biopsy” technology for cancer detection in dogs. Dr. Andi Flory will review the clinical applications of this innovative cell-free DNA-based technology and provide initial laboratory experience showing how this test is being used in veterinary practices across the country.

Title: Detect 30 different types of canine cancer with a simple blood draw: Introducing liquid biopsy testing. Description: At its most fundamental level, cancer is caused by abnormalities in DNA. Advanced genomic sequencing technologies now allow for the identification of these abnormalities using a simple blood draw, opening the door to non-invasive cancer detection in dogs. This session will provide a basic overview of cancer biology and introduce the fundamentals of liquid biopsy for canine cancer detection using next-generation sequencing of cell-free DNA. A review of the peer-reviewed clinical validation study of this testing in over 1,000 dogs will be presented, along with recent clinical laboratory experience and case examples from real-world veterinary practices. This program has been approved for 1 hour of continuing education credit in jurisdictions that recognize RACE approval (Tracking number 20-909052).